<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aoxing Pharmaceutical Company, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Aoxing Pharmaceutical Company, Inc.

    Aoxing Pharmaceutical Company Inc., is a specialty pharmaceutical company. The Company specializes in the research, development, manufacturing, and distribution of a variety of narcotics and pain-management products. Aoxing Pharmaceutical serves customers worldwide.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $5,000,000
    • PRE-MONEY EVAULATION
      $62,466,041.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Zhenjiang Yue
    • FOUNDED
      1997
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cutera, Inc.

    Cutera, Inc.

    CUTERA, Inc. was founded in 1998 and is a global provider of Face + Body laser, li...

    CUTERA, Inc. was founded in 1998 and is a globa...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Merck KGaA

    Merck KGaA

    Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates...

    Merck KGaA, Darmstadt, Germany, a leading scien...

    Filing Type:    PU
    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    Astellas Pharma, Inc.

    Astellas Pharma, Inc.

    Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fiel...

    Astellas Pharma Inc. is a pharmaceutical compan...

    Filing Type:    PU
    Allena Pharmaceuticals, Inc.

    Allena Pharmaceuticals, Inc.

    Allena’s lead product candidate, reloxaliase, is a first-in-class, oral enzyme t...

    Allena’s lead product candidate, reloxaliase,...

    Filing Type:    PU
    BioCurity Pharmaceuticals Inc.

    BioCurity Pharmaceuticals Inc.

    BioCurity is a clinical stage biopharmaceutical company with a mission to material...

    BioCurity is a clinical stage biopharmaceutical...

    Amount Raised:    $177,391.00
    Fundraising Status:    EC
    Filing Type:    CF
    Mylan N.V.

    Mylan N.V.

    Mylan is a global pharmaceutical company committed to setting new standards in hea...

    Mylan is a global pharmaceutical company commit...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.